Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

Now or never: Europe must seize the Pharma Legislation… 7 November 2023 Medicines for Europe, representing the European value-added medicines industry, is…
Scientific advice for continuous innovation in known… 5 May 2022 Open
A streamlined, digital regulatory framework is the… 27 September 2023 The off-patent medicines sector accounts for almost 70% of medicines…
One- Pager: New pricing models for generic medicines 10 October 2022 How can we ensure a sustainable healthcare system while safeguarding…